PFDSELECT MEDICAL RECEIVABLES 2002 LLC has recently filed an amendment to its previous securities offering. This filing, submitted on October 22, 2026, may reflect a strategic adjustment in the company's financial operations.
PFDSELECT MEDICAL RECEIVABLES 2002 LLC is a limited liability company based in Henderson, Nevada. The company focuses on medical receivables, which involves purchasing and managing medical debt. This sector is critical as it provides liquidity to healthcare providers while managing outstanding patient debts.
The filing indicates that the amendment pertains to Item 06c, which typically involves updates related to the offering of securities. Specific details regarding the nature of the changes were not disclosed in the filing. The filing was accepted by the SEC on October 21, 2026, and is effective as of the following day.
This amendment may affect various stakeholders, including investors and healthcare providers who rely on medical receivables for cash flow. The filing suggests that the company is actively managing its financial strategies in response to market conditions.
Details were not available in the SEC filing regarding the next steps following this amendment. However, the company may continue to adjust its offerings as it responds to the evolving landscape of medical receivables.
Company Information
PFDSELECT MEDICAL RECEIVABLES 2002 LLC has a Central Index Key (CIK) of 0002050336 and is registered under the Employer Identification Number (EIN) 332445018. The company is incorporated in the state of Nevada and has a fiscal year ending on December 31.
Contact Details
The company's mailing and business address is 11500 S. Eastern Ave., Suite #150, Henderson, NV 89052. For inquiries, they can be reached at the phone number 888-475-4748.
Regulatory Context
This amendment falls under the Securities Act of 1933, as indicated by the filing type D/A. The SEC file number associated with this offering is 021-534653, and it was filed under film number 261477043. These identifiers are crucial for tracking the filing within regulatory frameworks.
Future Considerations
While the filing does not provide specific details on the implications of the amendment or future plans, it is clear that the company is positioning itself to adapt to changing market dynamics in the medical receivables sector.











